References
Weissleder R (1999) Molecular imaging: exploring the next frontier. Radiology 212:609–14
Jager PL, de Korte MA, Lub-de Hooge MN et al (2005) Molecular imaging: what can be used today. Cancer Imaging 23;5 Spec No A:S27-32
Yamamoto Y, Nishiyama Y, Ishikawa S et al (2008) 3′-Deoxy-3′-18F-fluorothymidine as a proliferation imaging tracer for diagnosis of lung tumours: comparison with 2-deoxy-2-18f-fluoro-D-glucose. J Comput Assist Tomogr 32:432–437
Jager PL, Chirakal R, Marriott CJ et al (2008) 6-L-18F-fluorodihydroxyphenylalanine PET in neuroendocrine tumours: basic aspects and emerging clinical applications. J Nucl Med 49:573–586
Mohnike K, Blankenstein O, Minn H et al (2008) [18F]-DOPA positron emission tomography for preoperative localization in congenital hyperinsulinism. Horm Res 70:65–72
Beer AJ, Schwaiger M (2008) Imaging of integrin alphavbeta3 expression. Cancer Metastasis Rev 27:631–644
Langen KJ, Eschmann SM (2008) Correlative imaging of hypoxia and angiogenesis in oncology. T Nucl Med 49:515–516
Faust A, Wagner S, Law MP et al (2007) The nonpeptidyl caspase binding radioligand (S)-1-(4-(2-[18F]Fluoroethoxy)-benzyl)-5-[1-(2-methoxymethylpyrrolidinyl) sulfonyl]isatin ([18F]CbR) as potential positron emission tomography-compatible apoptosis imaging agent. Q J Nucl Med Mol Imaging 51:67–73
Körholz D, Kluge R, Wickmann L et al (2003) Importance of F18-fluorodeoxy-D-2-glucose positron emission tomography (FDG-PET) for staging and therapy control of Hodgkin’s lymphoma in childhood and adolescence—consequences for the GPOH-HD 2003 protocol. Onkologie 26:489–493
Gerth HU, Juergens KU, Dirksen U et al (2007) Significant benefit of multimodal imaging: PET/CT compared with PET alone in staging and follow-up of patients with Ewing tumours. J Nucl Med 48:1932–1939
Lang K, Kloska S, Straeter R et al (2005) Clinical value of amino acid imaging in paediatric brain tumours: Comparison with MRI. Nuklearmedizin 44:131–136
Langen KJ, Hamacher K, Weckesser M et al (2006) O-(2-[18F]fluoroethyl)-l-tyrosine: Uptake mechanisms and clinical applications. Nucl Med Biol 33:287–294
Weckesser M, Langen KJ, Rickert CH et al (2005) CH O-(2-[(18) F]fluorethyl)-L-tyrosine PET in the clinical evaluation of primary brain tumours. Eur J Nucl Med Mol Imaging 32:422–429
Weckesser M, Matheja P, Rickert CH et al (2001) High uptake of L-3-[123I]iodo-alpha-methyl tyrosine in pilocytic astrocytomas. Eur J Nucl Med 28:273–281
Utriainen M, Metsahonkala L, Salmi TT et al (2002) Metabolic characterisation of childhood brain tumours: Comparison of 18F-fluorodeoxyglucose and 11C-methionine positron emission tomography. Cancer 95:1376–1386
Messing-Jünger AM, Floeth FW, Pauleit D et al (2002) Multimodal target point assessment for stereotactic biopsy in children with diffuse bithalamic astrocytomas. Childs Nerv Syst 18:445–449
Pirotte B, Goldman S, Van Bogaert P et al (2005) Integration of [11C]methionine-positron emission tomographic and magnetic resonance imaging for image-guided surgical resection of infiltrative low-grade brain tumours in children. Neurosurgery 57(1 Suppl):128–139
Frühwald MC, O’Dorisio MS, Pietsch T et al (1999) High expression of somatostatin receptor subtype 2 (sst2) in medulloblastoma: implications for diagnosis and therapy. Pediatr Res 45:697–708
O’Dorisio MS, Khanna G, Bushnell D (2008) Combining anatomic and molecularly targeted imaging in the diagnosis and surveillance of embryonal tumours of the nervous and endocrine systems in children. Cancer Metastasis Rev 27:665–677
Kowalski J, Henze M, Schuhmacher J et al (2003) Evaluation of positron emission tomography imaging using [68Ga]-DOTA-D Phe(1)-Tyr(3)-Octreotide in comparison to [111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumours. Mol Imaging Biol 5:42–48
Franzius C, Hermann K, Weckesser M et al (2006) Whole-body PET/CT with 11C-meta-hydroxyephedrine in tumours of the sympathetic nervous system: feasibility study and comparison with 123I-MIBG SPECT/CT. J Nucl Med 47:1635–1642
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Weckesser, M. Molecular imaging with positron emission tomography in paediatric oncology—FDG and beyond. Pediatr Radiol 39 (Suppl 3), 450–455 (2009). https://doi.org/10.1007/s00247-009-1231-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00247-009-1231-8